OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NASDAQ: ACXIF 21.08%
NASDAQ: BATL 21.08%
NASDAQ: NGNE 21.08%
NASDAQ: KORE 21.08%
NASDAQ: DLLL 21.08%
